Diabeloop receives FDA 510(k) clearance for DBLG2, an Automated Insulin Delivery algorithm in an App
Diabeloop receives FDA 510(k) clearance for DBLG2, an Automated Insulin Delivery algorithm in an App: a strategic ...
The US FDA has cleared a new “basal insulin dose optimizer” function for the Dexcom G7 15-day continuous glucose monitor (CGM), which is set to launch separately on December 1, 2025. The “Smart Basal” ...
Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a global insulin delivery and diabetes technology company, today announced that the U.S. Food and Drug Administration (FDA) has cleared the Android version ...
Dexcom has issued a Class I recall for its G6 glucose sensor Android application due to a defect that causes the app to crash unexpectedly. As a result of the app terminating, users could miss ...
Dexcom recalled an Android app for its G6 glucose sensor due to a software problem that could cause the app to terminate unexpectedly. The issue could cause users to miss alarms, alerts or ...
This diabetes technology offers a continuous stream of data to show a more complete picture of your blood sugars over time. This is different from a fingerstick meter that only represents that moment.
Hosted on MSN
Xpeng G6 Charging Port Location and Design Overview
This video provides an overview of the charging port location and design on the Xpeng G6, highlighting its seamless integration into the vehicle’s bodywork. The segment demonstrates how the flap opens ...
Your device's unique device identifier and model number are on the back of your receiver. Some of Dexcom's continuous glucose monitoring receivers have been recalled due to speaker malfunctions, which ...
Dexcom is recalling 19 models of its continuous glucose monitoring receivers due to a speaker malfunction that could prevent alerts for dangerous blood sugar levels. The affected devices are models ...
Researchers in Denmark claim to have identified the best locations for rear plane-of-array irradiance sensors on the back of single-axis trackers in bifacial PV projects. Their work suggests how to ...
Medicare Part B may cover continuous glucose monitors (CGMs) for individuals with diabetes who require daily blood sugar testing, use insulin, or have a history of low blood sugar. To qualify for CGM ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results